JP2021524248A5 - - Google Patents
Info
- Publication number
- JP2021524248A5 JP2021524248A5 JP2020565274A JP2020565274A JP2021524248A5 JP 2021524248 A5 JP2021524248 A5 JP 2021524248A5 JP 2020565274 A JP2020565274 A JP 2020565274A JP 2020565274 A JP2020565274 A JP 2020565274A JP 2021524248 A5 JP2021524248 A5 JP 2021524248A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- chimeric antigen
- receptor
- amino acid
- antigen receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018901782A AU2018901782A0 (en) | 2018-05-21 | Chimeric Antigen Receptors with Modified Linker Domain and uses thereof | |
| AU2018901782 | 2018-05-21 | ||
| PCT/AU2019/050487 WO2019222796A1 (en) | 2018-05-21 | 2019-05-20 | Chimeric antigen receptors with modified linker domains and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021524248A JP2021524248A (ja) | 2021-09-13 |
| JP2021524248A5 true JP2021524248A5 (cg-RX-API-DMAC7.html) | 2022-05-16 |
Family
ID=68615492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565274A Pending JP2021524248A (ja) | 2018-05-21 | 2019-05-20 | 修飾されたリンカードメインを有するキメラ抗原受容体およびその使用 |
Country Status (11)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12121539B2 (en) | 2015-09-11 | 2024-10-22 | Biosceptre (Aust) Pty Ltd | Chimeric antigen receptors and uses thereof |
| EP4045648A4 (en) * | 2019-10-15 | 2023-11-22 | The Regents of The University of California | Transplanted cell protection via fc sequestration |
| CN111944062B (zh) * | 2019-12-09 | 2023-11-07 | 深圳市体内生物医药科技有限公司 | 一种识别Fc片段的嵌合抗原受体及其应用 |
| KR20220140800A (ko) * | 2020-02-12 | 2022-10-18 | 에스에이비, 엘엘씨 | 항-흉선세포 글로불린 |
| EP4204005A1 (en) | 2020-08-31 | 2023-07-05 | Sab, Llc | Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof |
| CA3211323A1 (en) * | 2021-03-11 | 2022-09-15 | Patrick Schlegel | Novel cell therapy system |
| JP2024532482A (ja) * | 2021-09-01 | 2024-09-05 | バイオセプター (オースト) プロプライエタリー・リミテッド | 免疫活性を刺激するための方法および組成物 |
| EP4476267A4 (en) * | 2022-02-11 | 2026-01-07 | Fred Hutchinson Cancer Center | CHIMERIC ANTIGENIC RECEPTORS BINDING TO STEAP1 |
| JP2025531675A (ja) * | 2022-09-14 | 2025-09-25 | バイオセプター (オースト) プロプライエタリー・リミテッド | 操作された免疫細胞の富化 |
| CN120187461A (zh) * | 2022-09-14 | 2025-06-20 | 生物权威(澳大利亚)有限责任公司 | 免疫细胞的体内检测 |
| US20260085104A1 (en) * | 2022-09-14 | 2026-03-26 | Biosceptre (Aust) Pty Ltd | Methods of detecting immune cells |
| WO2026035817A1 (en) * | 2024-08-06 | 2026-02-12 | Board Of Regents, The University Of Texas System | Suicide egfr-iii compositions and methods of use thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579821A (en) | 1981-11-23 | 1986-04-01 | University Patents, Inc. | Control of DNA sequence transcription |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4940661A (en) | 1984-05-17 | 1990-07-10 | Genentech, Inc. | Metallothionein transcription control sequences and use thereof |
| US5512483A (en) | 1993-05-21 | 1996-04-30 | Mcgill University | Expression vectors responsive to steroid hormones |
| US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| JPH11506319A (ja) | 1995-05-26 | 1999-06-08 | ゼネカ・リミテッド | エクジソンレセプターを含む遺伝子スイッチ |
| US5851796A (en) | 1995-06-07 | 1998-12-22 | Yale University | Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
| WO2001020155A1 (fr) * | 1999-09-16 | 2001-03-22 | Liangqi Zhang | Membrane de reduction de pression pour carburateur |
| WO2003020762A1 (en) | 2001-09-03 | 2003-03-13 | Intreat Pty Limited | Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| DK1751181T3 (da) | 2004-06-02 | 2012-11-26 | Adalta Pty Ltd | BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNER |
| US20100036101A1 (en) | 2006-10-10 | 2010-02-11 | Angus Gidley-Baird | Antibodies against non functional p2x7 receptor |
| WO2008043145A1 (en) | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Hybridomas producing antibodies against non functional p2x7 receptor |
| JP5670192B2 (ja) | 2007-09-14 | 2015-02-18 | バイオセプター・インターナショナル・リミテッド | 新規p2x7エピトープ |
| AU2009266430B2 (en) | 2008-07-04 | 2014-08-14 | Biosceptre International Limited | Anti- P2X7 peptides and epitopes |
| EP3395832B1 (en) | 2009-08-20 | 2021-11-24 | Biosceptre (Aust) Pty Ltd | Anti p2x7 receptor antibodies and fragments thereof |
| EP2516470B1 (en) | 2009-12-24 | 2018-02-07 | Biosceptre (Aust) Pty Ltd | Antibodies to non-functional oligomeric p2x7 receptors |
| EP3115373B1 (en) * | 2010-09-08 | 2019-08-28 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Chimeric antigen receptors with an optimized hinge region |
| WO2012073048A2 (en) | 2010-12-03 | 2012-06-07 | Cyclogenix Ltd | Binding peptides i |
| ES2688035T3 (es) * | 2014-08-29 | 2018-10-30 | Gemoab Monoclonals Gmbh | Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes |
| ES2738705T3 (es) * | 2014-09-19 | 2020-01-24 | Hope City | Linfocitos T de receptor de antígeno quimérico coestimulante que se dirigen a IL13R 2 |
| CN107429253B (zh) * | 2014-12-05 | 2021-11-05 | 希望之城公司 | Cs1靶向性嵌合抗原受体修饰的t细胞 |
| EP3250611B1 (en) * | 2015-01-26 | 2021-04-21 | The University of Chicago | Car t-cells recognizing cancer-specific il 13r-alpha2 |
| US12121539B2 (en) * | 2015-09-11 | 2024-10-22 | Biosceptre (Aust) Pty Ltd | Chimeric antigen receptors and uses thereof |
| CN114634569B (zh) * | 2016-04-15 | 2024-08-20 | 达特茅斯大学理事会 | 高亲和力b7-h6抗体和抗体片段 |
| WO2018017649A1 (en) * | 2016-07-19 | 2018-01-25 | Unum Therapeutics Inc. | Use of antibody-coupled t cell receptor (actr) with multiple anti-cancer antibodies in cancer treatment |
| EP3518944A4 (en) * | 2016-09-30 | 2020-06-17 | Baylor College of Medicine | ADAPTIVE CHIMERIC ANTIGENT RECEPTOR T-CELL DESIGN |
| EP3315511A1 (en) * | 2016-10-29 | 2018-05-02 | Miltenyi Biotec GmbH | Adapter chimeric antigen receptor expressing cells for targeting of multiple antigens |
-
2019
- 2019-05-20 AU AU2019275479A patent/AU2019275479B2/en active Active
- 2019-05-20 JP JP2020565274A patent/JP2021524248A/ja active Pending
- 2019-05-20 KR KR1020207033662A patent/KR20210013691A/ko not_active Ceased
- 2019-05-20 US US17/057,060 patent/US20220089718A1/en active Pending
- 2019-05-20 MX MX2020012445A patent/MX2020012445A/es unknown
- 2019-05-20 CA CA3099712A patent/CA3099712A1/en active Pending
- 2019-05-20 SG SG11202010451QA patent/SG11202010451QA/en unknown
- 2019-05-20 CN CN201980034413.2A patent/CN112166193A/zh active Pending
- 2019-05-20 EP EP19808128.3A patent/EP3797164A4/en active Pending
- 2019-05-20 WO PCT/AU2019/050487 patent/WO2019222796A1/en not_active Ceased
- 2019-05-20 BR BR112020023489A patent/BR112020023489A8/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240228636A1 (en) | mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS | |
| JP7797198B2 (ja) | ヒトpd-1に対する二機能性分子 | |
| CA3122526C (en) | Humanized anti-human-pd-1 antibody | |
| JP7807234B2 (ja) | 二機能性抗pd-1/il-7分子 | |
| JP7675012B2 (ja) | 二機能性抗pd-1/sirpa分子 | |
| AU2019299439A1 (en) | Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof | |
| CA3111706A1 (en) | Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereof | |
| KR20240099224A (ko) | 항원 결합 폴리펩티드, 항원 결합 폴리펩티드 복합체 및 이의 사용 방법 | |
| AU2022288574A1 (en) | Multispecific antibodies binding to cd20, nkp46, cd16 and conjugated to il-2 | |
| JP7319250B2 (ja) | Strep-タグ特異的結合タンパク質およびその使用 | |
| BR112017000664B1 (pt) | Anticorpo anti-pd-1, combinação de polinucleotídeos isolados, vetor de expressão, e composição farmacêutica | |
| JP2020528765A5 (cg-RX-API-DMAC7.html) | ||
| Mohammadi et al. | Immunotherapy For Researchers | |
| KR20240005741A (ko) | 특성이 향상된 이작용성 분자용 신규한 스캐폴드 | |
| JP7558534B2 (ja) | Cd137アゴニスト性抗体とその使用 | |
| WO2022258678A1 (en) | Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a | |
| WO2022258691A1 (en) | Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a | |
| US20230002488A1 (en) | Guidance and navigation control proteins and method of making and using thereof | |
| JP2026506471A (ja) | 組み換えFcドメイン-IL2バリアントポリペプチド及び膜アンカー抗原結合ポリペプチドとの併用療法 | |
| US20250101104A1 (en) | Bispecific molecule with tunable affinity to a targeted antigen | |
| WO2024028386A1 (en) | Multifunctional molecule directed against cd28 | |
| CN118252923A (zh) | 靶向nkg2d配体的融合蛋白与嵌合抗原受体细胞的组合及其用途 | |
| JP2022547650A (ja) | ヒトプログラム細胞死受容体pd-1に対する抗体 | |
| JP2025530110A (ja) | 二重特異性ポリペプチド及びその使用 | |
| WO2024238287A1 (en) | Dual blocking and chimeric cytokine receptor |